These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 30990265)

  • 61. Role of health technology assessment in shaping the benefits package in The Netherlands.
    Stolk EA; de Bont A; van Halteren AR; Bijlmer RJ; Poley MJ
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):85-94. PubMed ID: 19371181
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
    Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
    BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Review of Economic Submissions to NICE Medical Technologies Evaluation Programme.
    Alshreef A; Jenks M; Green W; Dixon S
    Appl Health Econ Health Policy; 2016 Dec; 14(6):623-634. PubMed ID: 27480537
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis.
    Kaltenthaler E; Carroll C; Hill-McManus D; Scope A; Holmes M; Rice S; Rose M; Tappenden P; Woolacott N
    Health Technol Assess; 2016 Apr; 20(26):1-48. PubMed ID: 27049841
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HARMONIZING HEALTH TECHNOLOGY ASSESSMENT PRACTICES IN UNIVERSITY HOSPITALS: TO WHAT EXTENT IS THE MINI-HTA MODEL SUITABLE IN THE FRENCH CONTEXT?
    Martelli N; Devaux C; van den Brink H; Billaux M; Pineau J; Prognon P; Borget I
    Int J Technol Assess Health Care; 2017 Jan; 33(2):307-314. PubMed ID: 28580892
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A consumer involvement model for health technology assessment in Canada.
    Pivik J; Rode E; Ward C
    Health Policy; 2004 Aug; 69(2):253-68. PubMed ID: 15212871
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA.
    Kristensen FB; Husereau D; Huić M; Drummond M; Berger ML; Bond K; Augustovski F; Booth A; Bridges JFP; Grimshaw J; IJzerman MJ; Jonsson E; Ollendorf DA; Rüther A; Siebert U; Sharma J; Wailoo A
    Value Health; 2019 Jan; 22(1):13-20. PubMed ID: 30661627
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Not Available].
    Mamzer MF; Dubois S; Saout C; ; Albin N; Béhier JM; Buisson A; Diebolt V; Delaitre O; Duguet C; Fagon JY; Gaillard S; Le Jeunne C; Mazars R; Micallef J; Nabarette H; Piazza L; Raynaud C; Varoqueaux N
    Therapie; 2018 Feb; 73(1):95-105. PubMed ID: 29478707
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Involving stakeholders and developing a policy for stakeholder involvement in the European network for health technology assessment, EUnetHTA.
    Nielsen CP; Lauritsen SW; Kristensen FB; Bistrup ML; Cecchetti A; Turk E;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():84-91. PubMed ID: 20030895
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A regulatory governance perspective on health technology assessment (HTA) in France: the contextual mediation of common functional pressures.
    Barron AJ; Klinger C; Shah SM; Wright JS
    Health Policy; 2015 Feb; 119(2):137-46. PubMed ID: 25458970
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Implicit factors influencing the HTA deliberative processes in 5 European countries: results from a mixed-methods research.
    Monleón C; Martin-Späth H; Crespo C; Dussart C; Toumi M
    Health Policy Open; 2023 Dec; 5():100109. PubMed ID: 38073709
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Strengthening patient outcome evidence in health technology assessment: a coproduction approach.
    Rasburn M; Livingstone H; Scott SE
    Int J Technol Assess Health Care; 2021 Jan; 37():e12. PubMed ID: 33436125
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Involving patients in the evaluation of health technologies at the French National Authority for Health (HAS)].
    Nabarette H
    Sante Publique; 2018; 30(6):767-775. PubMed ID: 30990265
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Exploration of the visibility of patient input in final recommendation documentation for three health technology assessment bodies.
    Wale JL; Sullivan M
    Int J Technol Assess Health Care; 2020 Jun; 36(3):197-203. PubMed ID: 32375904
    [TBL] [Abstract][Full Text] [Related]  

  • 77. INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES.
    Martelli N; Billaux M; Borget I; Pineau J; Prognon P; van den Brink H
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):12-8. PubMed ID: 25991072
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.